Mee‐Young Ahn

971 citations
28 papers · 844 indexed · h-index 18
Topics
Histone Deacetylase Inhibitors Research (7 papers)Protein Degradation and Inhibitors (5 papers)Peptidase Inhibition and Analysis (3 papers)

In The Last Decade

Mee‐Young Ahn

28 papers receiving 832 citations

Peers

Mee‐Young Ahn
Comparison fields: 5 of 92
  • Molecular Biology 565
  • Oncology 116
  • Immunology 110
  • Cancer Research 95
  • Hematology 90
Replace Carlos Lopes with:
Carlos Lopes Portugal
Vibha Singh India
Hongyu Zhao China
Hyeong‐jun Han South Korea
Yoshiko Hoshikawa Japan
Hui-Wen Cheng Taiwan
Changyou Li United States
Ross O. Meyers United States
Nyree Crawford United Kingdom
Praveenkumar Shetty India
Mee‐Young Ahn relative to Carlos Lopes Portugal Carlos Lopes's profile →
Citations per field
00.5×1.6×
Carlos Lopes · 1×
Citations per year

Countries citing papers authored by Mee‐Young Ahn

Since Specialization
Citations

This map shows the geographic impact of Mee‐Young Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mee‐Young Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mee‐Young Ahn more than expected).

Fields of papers citing papers by Mee‐Young Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mee‐Young Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mee‐Young Ahn. The network helps show where Mee‐Young Ahn may publish in the future.

Co-authorship network of co-authors of Mee‐Young Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Mee‐Young Ahn. A scholar is included among the top collaborators of Mee‐Young Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mee‐Young Ahn. Mee‐Young Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 3
3 20
4 23
5 38
6 48
7 27
8 22
9 40
10 14
11 36
12 27
13 51
14 61
15 17
16 38
17 10
18 71
19 17
20 74

About Mee‐Young Ahn

Mee‐Young Ahn is a scholar working on Nephrology, Hematology and Otorhinolaryngology, having authored 28 papers that have together received 844 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Molecular Biology (565 citations), Hematology (90 citations) and Periodontics (32 citations). Mee‐Young Ahn has collaborated with scholars based in South Korea, Japan and United Kingdom. Frequent co-authors include Jung‐Hoon Yoon, Sang‐Gun Ahn, Suk‐Chul Bae, Yoshiaki Ito, Tahir S Pillay, Hyo‐Eun Yoon, Kostas D. Katsanakis, Hyung Sik Kim, Yong‐Chul Kim and Woo‐Young Kim. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026